Montelukast does not increase the risk of attention-deficit/hyperactivity disorder in pediatric asthma patients: A nationwide population-based matched cohort study.

CONCLUSION: This nationwide population-based cohort study reveals that asthma children treated with montelukast were not at an increased risk of developing ADHD. Nevertheless, validation of our retrospective survey requires further prospective study. PMID: 33158697 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33158697?dopt=Abstract

Source: J Formos Med Assoc - November 3, 2020 Category: General Medicine Authors: Huang PY, Yang YH, Huang YH, Kuo HC, Wang LJ, Chien SJ, Chang LS Tags: J Formos Med Assoc Source Type: research